Par-4 induces cholinergic hypoactivity by suppressing ChAT protein synthesis and inhibiting NGF-inducibility of ChAT activity

Brain Research

Volumn 874, Issue 2, 2000, Pages 221-232

  Guo, Qing ^a   Xie, Jun ^b   Du, Huimin ^a  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Amyloid peptide; Choline acetyl transferase; Nerve growth factor; Neurotransmitter; Par 4

Indexed keywords

AMYLOID BETA PROTEIN; CHOLINE ACETYLTRANSFERASE; LEUCINE ZIPPER PROTEIN; NERVE GROWTH FACTOR;

ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; ARTICLE; CHOLINERGIC ACTIVITY; CHOLINERGIC TRANSMISSION; COGNITION; CONTROLLED STUDY; ENZYME INDUCTION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; RAT;

AMYLOID BETA-PROTEIN; ANIMALS; APOPTOSIS REGULATORY PROTEINS; CARRIER PROTEINS; CHOLINE O-ACETYLTRANSFERASE; ENZYME INDUCTION; GENE EXPRESSION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUCINE ZIPPERS; NERVE GROWTH FACTOR; OSMOLAR CONCENTRATION; PC12 CELLS; PEPTIDE FRAGMENTS; RATS;

EID: 0034714361     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02559-2     Document Type: Article

References (83)

1. T. Arendt, M. Holzer, H.J. Gertz, M.K. Bruckner, Cortical load of PHF-tau in Alzheimer's disease is correlated to cholinergic dysfunction, J. Neural Transm. 106 (1999) 513-523.
2. R.T. Bartus, D.F. Emerich, Cholinergic markers in Alzheimer disease, J. Am. Med. Assoc. 282 (1999) 2208-2209, letter, comment.
3. R.T. Bartus, R.L.d. Dean, B. Beer, A.S. Lippa, The cholinergic hypothesis of geriatric memory dysfunction, Science 217 (1982) 408-414.
4. D.S. Baskin, J.L. Browning, F.J. Pirozzolo, S. Korporaal, J.A. Baskin, S.H. Appel, Brain choline acetyltransferase and mental function in Alzheimer disease, Arch. Neurol. 56 (1999) 1121-1123.
5. L.M. Bierer, V. Haroutunian, S. Gabriel, P.J. Knott, L.S. Carlin, D.P. Purohit, D.P. Perl, J. Schmeidler, P. Kanof, K.L. Davis, Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits, J. Neurochem. 64 (1995) 749-760.
6. O. Bugiani, Pathogenesis of Alzheimer's disease and dementia, Rev. Neurol. (Paris) 155 (1999) S28-S32.
7. J.R. Burke, J.C. Morgenlander, Update on Alzheimer's disease. Promising advances in detection and treatment, Postgrad. Med. 106 (1999) 85-86, 89-90, 93-84 passim.
8. S.L. Chan, W.S. Griffin, M.P. Mattson, Evidence for caspase-mediated cleavage of AMPA receptor subunits in neuronal apoptosis and Alzheimer's disease, J. Neurosci. Res. 57 (1999) 315-323.
9. C.W. Cotman, Apoptosis decision cascades and neuronal degeneration in Alzheimer's disease, Neurobiol. Aging 19 (1998) S29-S32.
10. S.M. de la Monte, Molecular abnormalities of the brain in Down syndrome: relevance to Alzheimer's neurodegeneration, J. Neural Transm. Suppl. 57 (1999) 1-19.
11. G. Deng, C.J. Pike, C.W. Cotman, Alzheimer-associated presenilin-2 confers increased sensitivity to apoptosis in PC12 cells, FEBS Lett. 397 (1996) 50-54.
12. M.T. Diaz-Meco, M.M. Municio, S. Frutos, P. Sanchez, J. Lozano, L. Sanz, J. Moscat, The product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase C, Cell 86 (1996) 777-786.
13. G. Emilien, J.M. Maloteaux, K. Beyreuther, C.L. Masters, Alzheimer disease: mouse models pave the way for therapeutic opportunities, Arch. Neurol. 57 (2000) 176-181.
14. O. Felician, T.A. Sandson, The neurobiology and pharmacotherapy of Alzheimer's disease, J. Neuropsychiatry Clin. Neurosci. 11 (1999) 19-31.
15. G. Forloni, R. Chiesa, S. Smiroldo, L. Verga, M. Salmona, F. Tagliavini, N. Angeretti, Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35, Neuroreport 4 (1993) 523-526.
16. H. Forstl, A. Kurz, Clinical features of Alzheimer's disease, Eur. Arch. Psychiatry Clin. Neurosci. 249 (1999) 288-290.
17. P.T. Francis, A.M. Palmer, M. Snape, G.K. Wilcock, The cholinergic hypothesis of Alzheimer's disease: a review of progress, J. Neurol. Neurosurg. Psychiatry 66 (1999) 137-147, see comments.
18. S.Y. Guenette, R.E. Tanzi, Progress toward valid transgenic mouse models for Alzheimer's disease, Neurobiol. Aging 20 (1999) 201-211.
19. Q. Guo, N. Robinson, M.P. Mattson, Secreted beta-amyloid precursor protein counteracts the proapoptotic action of mutant presenilin-1 by activation of NF-kappaB and stabilization of calcium homeostasis, J. Biol. Chem. 273 (1998) 12341-12351.
20. Q. Guo, L. Sebastian, B.L. Sopher, M.W. Miller, C.B. Ware, G.M. Martin, M.P. Mattson, Increased vulnerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid beta-peptide toxicity: central roles of Superoxide production and caspase activation, J. Neurochem. 72 (1999) 1019-1029.
21. Q. Guo, W. Fu, F.W. Holtsberg, S.M. Steiner, M.P. Mattson, Superoxide mediates the cell-death-enhancing action of presenilin-1 mutations, J. Neurosci. Res. 56 (1999) 457-470.
22. Q. Guo, S. Christakos, N. Robinson, M.P. Mattson, Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: reduced oxidative stress and preserved mitochondrial function, Proc. Natl. Acad. Sci. USA 95 (1998) 3227-3232.
23. Q. Guo, K. Furukawa, B.L. Sopher, D.G. Pham, J. Xie, N. Robinson, G.M. Martin, M.P. Mattson, Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide, Neuroreport 8 (1996) 379-383.
24. Q. Guo, B.L. Sopher, K. Furukawa, D.G. Pham, N. Robinson, G.M. Martin, M.P. Mattson, Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals, J. Neurosci. 17 (1997) 4212-4222.
25. Q. Guo, W. Fu, J. Xie, H. Luo, S.F. Sells, J.W. Geddes.V. Bondada, V.M. Rangnekar, M.P. Mattson, Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease, Nat. Med. 4 (1998) 957-962, see comments.
26. C. Haass, B. De Strooper, The presenilins in Alzheimer's disease - proteolysis holds the key, Science 286 (1999) 916-919.
27. M. Hahn, S.L. Hahn, D.M. Stone, T.H. Joh, Cloning of the rat gene encoding choline acetyltransferase, a cholinergic neuron-specific marker, Proc. Natl. Acad. Sci. USA 89 (1992) 4387-4391.
28. J. Harada, M. Sugimoto, Activation of caspase-3 in beta-amyloid-induced apoptosis of cultured rat cortical neurons, Brain Res. 842 (1999) 311-323.
29. P. Honegger, P. Du Pasquier, M. Tenot, Cholinergic neurons of fetal rat telencephalon in aggregating cell culture respond to NGF as well as to protein kinase C-activating tumor promoters, Brain Res. 394 (1986) 217-223.
30. K. Horsburgh, D. Dewar, D.I. Graham, J. McCulloch, Autoradiographic imaging of [3H]phorbol 12,13-dibutyrate binding to protein kinase C in Alzheimer's disease, J. Neurochem. 56 (1991) 1121-1129.
31. M. Hoshi, A. Takashima, M. Murayama, K. Yasutake, N. Yoshida, K. Ishiguro, T. Hoshino, K. Imahori, Nontoxic amyloid beta peptide 1-42 suppresses acetylcholine synthesis. Possible role in cholinergic dysfunction in Alzheimer's disease, J. Biol. Chem. 272 (1997) 2038-2041.
32. K.J. Ivins, E.T. Bui, C.W. Cotman, Beta-amyloid induces local neurite degeneration in cultured hippocampal neurons: evidence for neuritic apoptosis, Neurobiol. Dis. 5 (1998) 365-378.
33. R.W. Johnstone, R.H. See, S.F. Sells, J. Wang, S. Muthukkumar, C. Englert, D.A. Haber, J.D. Licht, S.P. Sugrue, T. Roberts, V.M. Rangnekar, Y. Shi, A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1, Mol. Cell. Biol. 16 (1996) 6945-6956.
34. C. Kalberg, S.Y. Yung, J.A. Kessler, The cholinergic stimulating effects of ciliary neurotrophic factor and leukemia inhibitory factor are mediated by protein kinase C, J. Neurochem. 60 (1993) 145-152.
35. T.W. Kim, W.H. Pettingell, Y.K. Jung, D.M. Kovacs, R.E. Tanzi, Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease, Science 277 (1997) 373-376.
36. E.S. Kim, R.S. Kim, R.F. Ren, D.B. Hawver, K.C. Flanders, Transforming growth factor-beta inhibits apoptosis induced by beta-amyloid peptide fragment 25-35 in cultured neuronal cells, Brain Res. Mol. Brain Res. 62 (1998) 122-130.
37. Y. Kitamura, T. Taniguchi, S. Shimohama, Apoptotic cell death in neurons and glial cells: implications for Alzheimer's disease, Jpn. J. Pharmacol. 79 (1999) 1-5.
38. N.V. Koudinova, T.T. Berezov, A.R. Koudinov, Beta-amyloid: Alzheimer's disease and brain beta-amyloidoses, Biochemistry (Mosc) 64 (1999) 752-757.
39. D.M. Kovacs, R. Mancini, J. Henderson, S.J. Na, S.D. Schmidt, T.W. Kim, R.E. Tanzi, Staurosporine-induced activation of caspase-3 is potentiated by presenilin 1 familial Alzheimer's disease mutations in human neuroglioma cells, J. Neurochem. 73 (1999) 2278-2285.
40. W.J. Krall, J.J. Sramek, N.R. Cutler, Cholinesterase inhibitors: a therapeutic strategy for Alzheimer disease, Ann. Pharmacother. 33 (1999) 441-450.
41. J. Lemiere, D. Van Gool, R. Dom, Treatment of Alzheimer's disease: an evaluation of the cholinergic approach, Acta Neurol. Belg. 99 (1999) 96-106.
42. Q.X. Li, S.J. Fuller, K. Beyreuther, C.L. Masters, The amyloid precursor protein of Alzheimer disease in human brain and blood, J. Leukocyte Biol. 66 (1999) 567-574.
43. C.F. Lippa, Familial Alzheimer's disease: genetic influences on the disease process (review), Int. J. Mol. Med. 4 (1999) 529-536.
44. A. Marutle, U. Warpman, N. Bogdanovic, L. Lannfelt, A. Nordberg, Neuronal nicotinic receptor deficits in Alzheimer patients with the Swedish amyloid precursor protein 670/671 mutation, J. Neurochem. 72 (1999) 1161-1169.
45. M.P. Mattson, W.A. Pedersen, Effects of amyloid precursor protein derivatives and oxidative stress on basal forebrain cholinergic systems in Alzheimer's disease, Int. J. Dev. Neurosci. 16 (1998) 737-753.
46. M.P. Mattson, Q. Guo, K. Furukawa, W.A. Pedersen, Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimer's disease, J. Neurochem. 70 (1998) 1-14.
47. E.D. Menschik, L.H. Finkel, Cholinergic neuromodulation and Alzheimer's disease: from single cells to network simulations, Prog. Brain Res. 121 (1999) 19-45.
48. Z. Nagy, Mechanisms of neuronal death in Down's syndrome, J. Neural Transm. Suppl. 57 (1999) 233-245.
49. T. Nakagawa, H. Zhu, N. Morishima, E. Li, J. Xu, B.A. Yankner, J. Yuan, Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta, Nature 403 (2000) 98-103.
50. M. Nishimura, G. Yu, PH. St George-Hyslop, Biology of presenilins as causative molecules for Alzheimer disease, Clin. Genet. 55 (1999) 219-225.
51. O.F. Olesen, L. Dago, J.D. Mikkelsen, Amyloid beta neurotoxicity in the cholinergic but not in the serotonergic phenotype of RN46A cells, Brain Res. Mol. Brain Res. 57 (1998) 266-274.
52. B.J. Passer, L. Pellegrini, P. Vito, J.K. Ganjei, L. D'Adamio, Interaction of Alzheimer's presenilin-1 and presenilin-2 with Bcl-X(L). A potential role in modulating the threshold of cell death, J. Biol. Chem. 274 (1999) 24007-24013.
53. J. Pavia, M.L. de Ceballos, F. Sanchez de la Cuesta, Alzheimer's disease: relationship between muscarinic cholinergic receptors, beta-amyloid and tau proteins, Fundam. Clin. Pharmacol. 12 (1998) 473-481.
54. W.A. Pedersen, M.A. Kloczewiak, J.K. Blusztajn, Amyloid beta-protein reduces acetylcholine synthesis in a cell line derived from cholinergic neurons of the basal forebrain, Proc. Natl. Acad. Sci. USA 93 (1996) 8068-8071.
55. W.A. Pedersen, Q. Guo, B.K. Hartman, M.P. Mattson, Nerve growth factor-independent reduction in choline acetyltransferase activity in PC12 cells expressing mutant presenilin-1, J. Biol. Chem. 272 (1997) 22397-22400.
56. A. Petronis, Alzheimer's disease and Down syndrome: from meiosis to dementia, Exp. Neurol. 158 (1999) 403-413.
57. J.L. Pongrac, R.J. Rylett, Molecular mechanisms regulating NGF-mediated enhancement of cholinergic neuronal phenotype: c-fos trans-activation of the choline acetyltransferase gene, J. Mol. Neurosci. 11 (1998) 79-93.
58. M.R. Roberson, L.E. Harrell, Cholinergic activity and amyloid precursor protein metabolism, Brain Res. Brain Res. Rev. 25 (1997) 50-69.
59. M. Schmitt, P. Bausero, P. Simoni, D. Queuche, V. Geoffroy, C. Marschal, J. Kempf, C. Quirin-Stricker, Positive and negative effects of nuclear receptors on transcription activation by AP-1 of the human choline acetyltransferase proximal promoter, J. Neurosci. Res. 40 (1995) 152-164.
60. D.J. Selkoe, Translating cell biology into therapeutic advances in Alzheimer's disease, Nature 399 (1999) A23-A31.
61. S.F. Sells, D.P. Wood Jr., S.S. Joshi-Barve, S. Muthukumar, R.J. Jacob, S.A. Crist, S. Humphreys, V.M. Rangnekar, Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and -independent prostate cells Cell Growth Differ. 5 (1994) 457-466.
62. S.F. Sells, S.S. Han, S. Muthukkumar, N. Maddiwar, R. Johnstone, E. Boghaert, D. Gillis, G. Liu, P. Nair, S. Monnig, P. Collini, M.P. Mattson, V.P. Sukhatme, S.G. Zimmer, D.P. Wood Jr., J.W. McRoberts, Y. Shi, V.M. Rangnekar, Expression and function of the leucine zipper protein Par-4 in apoptosis, Mol. Cell. Biol. 17 (1997) 3823-3832.
63. B.S. Shastry, F.J. Giblin, Genes and susceptible loci of Alzheimer's disease, Brain Res. Bull. 48 (1999) 121-127.
64. J. Sirvio, Strategies that support declining cholinergic neurotrans-mission in Alzheimer's disease patients, Gerontology 45 (1999) 3-14.
65. G. Smale, N.R. Nichols, D.R. Brady, C.E. Finch, W.E. Horton Jr., Evidence for apoptotic cell death in Alzheimer's disease, Exp. Neurol. 133 (1995) 225-230.
66. D.H. Small, C.A. McLean, Alzheimer's disease and the amyloid beta protein: what is the role of amyloid?, J. Neurochem. 73 (1999) 443-449.
67. C. Soto, Alzheimer's and prion disease as disorders of protein conformation: implications for the design of novel therapeutic approaches, J. Mol. Med. 77 (1999) 412-418.
68. H. Steiner, A. Capell, U. Leimer, C. Haass, Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease, Eur. Arch. Psychiatry Clin. Neurosci. 249 (1999) 266-270.
69. E. Storey, R. Cappai, The amyloid precursor protein of Alzheimer's disease and the Abeta peptide, Neuropathol. Appl. Neurobiol. 25 (1999) 81-97.
70. J. Tol, G. Roks, A.J. Slooter, C.M. van Duijn, Genetic and environmental factors in Alzheimer's disease, Rev. Neurol. (Paris) 155 (1999) S10-S16.
71. F.W. van Leeuwen, E.M. Hol, Molecular misreading of genes in Down syndrome as a model for the Alzheimer type of neurodegeneration, J. Neural Transm. Suppl. 57 (1999) 137-159.
72. P. Vito, B. Wolozin, J.K. Ganjei, K. Iwasaki, E. Lacana, L. D'Adamio, Requirement of the familial Alzheimer's disease gene PS2 for apoptosis. Opposing effect of ALG-3, J. Biol. Chem. 271 (1996) 31025-31028.
73. A. Weidemann, K. Paliga, D.r. U, F.B. Reinhard, O. Schuckert, G. Evin, C.L. Masters, Proteolytic processing of the Alzheimer's disease amyloid precursor protein within its cytoplasmic domain by caspase-like proteases, J. Biol. Chem. 274 (1999) 5823-5829.
74. C.C. Weihl, R.J. Miller, R.P. Roos, The role of beta-catenin stability in mutant PS1-associated apoptosis, Neuroreport 10 (1999) 2527-2532.
75. C.C. Weihl, G.D. Ghadge, S.G. Kennedy, N. Hay, R.J. Miller, R.P. Roos, Mutant presenilin-1 induces apoptosis and downregulates Akt/PKB, J. Neurosci. 19 (1999) 5360-5369.
76. P.J. Whitehouse, D.L. Price, R.G. Struble, A.W. Clark, J.T. Coyle, M.R. Delon, Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain, Science 215 (1982) 1237-1239.
77. M.S. Wolfe, J. De Los Angeles, D.D. Miller, W. Xia, D.J. Selkoe, Are presenilins intramembrane-cleaving proteases? Implications for the molecular mechanism of Alzheimer's disease, Biochemistry 38 (1999) 11223-11230.
78. B. Wolozin, K. Iwasaki, P. Vito, J.K. Ganjei, E. Lacana, T. Sunderland, B. Zhao, J.W. Kusiak, W. Wasco, L. D'Adamio, Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation, Science 274 (1996) 1710-1713.
79. T.P. Wong, T. Debeir, K. Duff, A.C. Cuello, Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes, J. Neurosci. 19 (1999) 2706-2716.
80. G. Wortwein, J. Yu, T. Toliver-Kinsky, J.R. Perez-Polo, Responses of young and aged rat CNS to partial cholinergic immunolesions and NGF treatment, J. Neurosci. Res. 52 (1998) 322-333.
81. X.Z. Yan, J.T. Qiao, Y. Dou, Z.D. Qiao, Beta-amyloid peptide fragment 31-35 induces apoptosis in cultured cortical neurons, Neuroscience 92 (1999) 177-184.
82. X. Yan, R. Xiao, Y. Dou, S. Wang, Z. Qiao, J. Qiao, Carbachol blocks beta-amyloid fragment 31-35-induced apoptosis in cultured cortical neurons, Brain Res. Bull. 51 (2000) 465-470.
83. Z. Zhang, H. Hartmann, V.M. Do, D. Abramowski, C. Sturchler-Pierrat, M. Staufenbiel, B. Sommer, M. van de Wetering, H. Clevers, P. Saftig, B. De Strooper, X. He, B.A. Yankner, Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis, Nature 395 (1998) 698-702.